CONFIDNTIAL October 16, 2023 Eric R. Olson, Ph.D. By Electronic MailLetter Agreement • March 27th, 2024 • Syros Pharmaceuticals, Inc. • Pharmaceutical preparations
The purpose of this letter agreement (the “Agreement”) is to set forth the terms of your separation from Syros Pharmaceuticals, Inc. (“Syros” or “the Company”). We appreciate your contributions to the Company and wish you the best in your future endeavors.
